title: Distal embolic protection during percutaneous intervention of aorto-coronary venous bypass grafts: the FIRST Trial.
abstract: OBJECTIVE
  Interventions in aorto-coronary venous bypass grafts (CABG) can cause acute procedural complications due to distal embolization of debris. In the FIRST (First European Investigation Regarding the Systematic use of the TriActiv device) multicenter trial the distal endovascular protection system TriActiv (Kensey Nash) was evaluated during intervention of CABG.
  
  
  METHODS
  195 patients in 17 centers in Germany with significant disease of a vein graft were enrolled. Inclusion and exclusion criteria were comparable to the SAFER trial.
  
  
  RESULTS
  Acute procedural success was achieved in 98% of cases. Aspirated debris was found in 96.5% of patients. Primary endpoints (MACE at 30 days) occurred in 8.7% of all pts. (ITT). No patient died and 7.2% of patients suffered from MI. The rate of early revascularization was 1.5%. Secondary endpoints (MACCE at 30 days) were found in 9.2% and at hospital discharge in 8.7% of patients.
  
  
  CONCLUSIONS
  The TriActiv system is safe and effective. Normal post procedural flow can be preserved and the MACE rate is with 8.7% considerably low. The FIRST trial supports the growing belief that PCI of CABG should be performed with protection systems.
authors: University Clinic Schleswig-Holstein, Campus Kiel, Department of Cardiology, Schittenhelmstrasse 12, 24105 Kiel, Germany.
authors: M
authors: M
authors: Lins
authors: H
authors: H
authors: Heuer
authors: M
authors: M
authors: Haude
authors: P
authors: P
authors: Braun
authors: F
authors: F
authors: Stahl
authors: N
authors: N
authors: Franz
authors: R
authors: R
authors: Simon
mesh_terms: D000368:Aged; D001011:Aorta / Q000601:surgery*; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D004617:Embolism / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*
references: Am Heart J. 2005 Jun;149(6):1136
references: 15976802
references: Circulation. 2002 Dec 10;106(24):3063-7
references: 12473552
references: Circulation. 1999 Dec 14;100(24):2400-5
references: 10595951
references: J Am Coll Cardiol. 2005 Oct 18;46(8):1434-45
references: 16226166
references: J Am Coll Cardiol. 1998 Feb;31(2):241-51
references: 9462562
references: N Engl J Med. 1994 Feb 24;330(8):523-8
references: 8043066
references: Circulation. 2002 Mar 19;105(11):1285-90
references: 11901037
references: Circulation. 1994 Jun;89(6):2514-8
references: 8205658
references: J Am Coll Cardiol. 2005 Nov 1;46(9):1677-83
references: 16256868
references: Circulation. 2000 Feb 8;101(5):570-80
references: 10662756
references: J Am Coll Cardiol. 1999 Aug;34(2):468-75
references: 10440161
references: Circulation. 2003 Aug 5;108(5):548-53
references: 12874191
references: Circulation. 2003 Jul 8;108(1):37-42
references: 12821546